XOMA 031 is a naive human Fab phage display
library with more than 300 billion clones covering the human antibody repertoire.
In vivo biopanning with PhD-7 phage display
Academic and corporate chemists, biologists, and medical specialists describe the combinatorial technology phage display
and its role in drug discovery.
Antibody to M13 phage is instrumental in the titration of M13 phages during phage display
panning and in the detection of antigen-specific phages by means of their displayed antibody fragments, e.
XOMA's extensive antibody expertise includes phage display
library construction, antibody discovery, optimization, preclinical and clinical development, regulatory affairs, and cGMP manufacturing.
The researchers' success demonstrates that antibody phage display
can be used to select antibodies for pathogen detection--even where traditional methods have proved inadequate.
selection of peptides that affect prostate carcinoma cells attachment and invasion.
said Monday it has signed an agreement with Cambridge Antibody Technology (CAT) to license the British firm's antibody phage display
libraries to Chugai.
and cloning: Macrophages or phages are viruses that attack bacteria and plant cells (see Fig.
Dyax has granted Amersham a non-exclusive license to its phage display
affinity ligand discovery process for finding ligands for use in chromatography separations.
NASDAQ: DYAX) announced today, based on successful antibody discovery work during a research evaluation period, Bayer Pharma AG (Bayer) has executed a license to Dyax's antibody phage display
technology for development and potential commercialization of therapeutic antibody candidates identified using the Dyax library.
to remain as the predominant antibody library technology in 2017 and beyond.